US Patent

US8617600 — Modified release preparations containing oxcarbazepine and derivatives thereof

Formulation · Assigned to Supernus Pharmaceuticals Inc · Expires 2027-04-13 · 1y remaining

Vulnerability score 65/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects controlled-release preparations of oxcarbazepine and its derivatives for once-a-day administration with tailored release profiles.

USPTO Abstract

Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
US8617600
Jurisdiction
US
Classification
Formulation
Expires
2027-04-13
Drug substance claim
No
Drug product claim
Yes
Assignee
Supernus Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.